Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: A prospective, multicenter, randomized, controlled, double blind trial

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 6, Issue 4, 2001, Pages 341-350

  Galperin, Jorge ^a,b   Elizari, Marcelo V ^a,c   Chiale, Pablo A ^a,c   Molina, Remberto Torres ^a,c   Ledesma, Rauil ^a,d   Scapin, Angel O ^a,e   Blanco, Manuel Vaizquez ^a,f  

^a GEFACA Investigators GEMA Group   (Argentina)

^b HOSPITAL DURAND   (Argentina)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

^d Instituto Del Corazon   (Argentina)

^e GEMA   (Argentina)

^f HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Antiarrhythmic drugs; Arrhythmia; Cardioversion

Indexed keywords

AMIODARONE; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVERSION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SINUS BRADYCARDIA; SINUS RHYTHM; SKIN DISCOLORATION; TREATMENT OUTCOME;

EID: 0035711672     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840100600403     Document Type: Article

References (31)

1. Epidemiologic features of chronic atrial fibrillation: The Framingham Study
2. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
3. Hemodynamic and cardiorespiratory function following internal atrial defibrillation for chronic atrial fibrillation
4. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation
5. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized control trials
6. Efficacy, safety and determinants of conversion of atrial fibrillation and flutter with oral amiodarone
7. Low dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter
8. Efficacy of amiodarone for the termination of persistent atrial fibrillation
9. Electrical cardioversion after amiodarone administration
10. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation
11. Amiodarone to prevent recurrence of atrial fibrillation
12. Treatment strategies for atrial fibrillation
13. Cardioversion of chronic atrial fibrillation - Towards a more aggressive approach?
14. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
15. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT)
16. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: Results of a comparative study and a 2-year follow-up
17. Propafenone for conversion and prophylaxis of atrial fibrillation
18. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide
19. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
20. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
21. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful directcurrent cardioversion
22. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation
23. Success of chronic defibrillation and the role of the antiarrhythmic drogs with the automatic implantable cardioverter/defibrillator
24. Effects of chronic amiodarone therapy on the fibrillation threshold
25. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter
26. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation
27. Functional capacity before and after cardioversion of atrial fibrillation: A controlled study
28. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
29. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
30. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The cardiac arrhythmia suppression trial
31. Amiodaroneassociated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia